Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: breast cancer cell

<< < Results 201 - 300 of 309 > >>
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Show all pathways known for 3.4.19.9Display the word mapDisplay the reaction diagram Show all sequences 3.4.19.9folate gamma-glutamyl hydrolase breast cancer cell - 683368
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.106hepsin breast cancer cell upregulation of hepsin mRNA in estrogen receptor alpha-positive breast tumors compared with estrogen receptor alpha-negative breast tumors 686903
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.109matriptase breast cancer cell - 683364, 683489, 683492, 683494, 683763, 683893, 695463, 717902
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.109matriptase breast cancer cell strong expression association between matriptase and its substrate prostasin in breast cancer 717902
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme breast cancer cell - 707996
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme breast cancer cell enzyme expression analysis in 155 patients, overview 664622
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme breast cancer cell in contrast to the expression in ovarian cancer, high expression of KLK 7 is strongly associated with good prognosis in breast cancer patients 691153
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme breast cancer cell lymph node metastasis 707996
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.35tissue kallikrein breast cancer cell - 678522, 752895
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.45complement factor I breast cancer cell - 753137
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.59Tryptase breast cancer cell significantly more tryptase in peritumoral tissue than in normal breast tissue 710170
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.61Kexin breast cancer cell - 754945
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.73u-Plasminogen activator breast cancer cell - 709912, 710163
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.75Furin breast cancer cell - 707598, 708162, 708242, 708753
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B25PACE4 proprotein convertase breast cancer cell - 679039
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B28fibroblast activation protein alpha subunit breast cancer cell - 672907
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B28fibroblast activation protein alpha subunit breast cancer cell FAP-alpha is significantly increased in breast cancer patients with poor outcome and survival 731551
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B39stratum corneum tryptic enzyme breast cancer cell expression levels of KLK5 and KLK7 in benign breast tissues and metastases, and the relationship between KLK5 and KLK7 expression and and clinicopathological factors. mRNA levels of KLK5 and KLK7 in normal breast tissues, benign breast tissues, primary tumors, and lymph node metastases, overview. mRNA levels of KLK5 and KLK7 are both downregulated in breast cancers relative to normal and benign tissues, and downregulated in metastases compared to primary cancers 707996
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B39stratum corneum tryptic enzyme breast cancer cell no expression 670978
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 breast cancer cell - 678524, 678530, 679256
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 breast cancer cell downregulation due to hypermethylation of exon 3 667874
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 breast cancer cell KLK10 is not methylated in normal breast tissues and fibroadenomas while it is in 5 of 10 breast tumors and in 1 of 10 matching normal tissues 690443
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B43kallikrein 12 breast cancer cell - 679276
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B43kallikrein 12 breast cancer cell enzyme splice variant KLK12sv3 is more frequently expressed in tumors of lower grade, early patient TNM stage, and smaller tumor size, overview 732958
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B45kallikrein 14 breast cancer cell KLK14 expression significantly higher compared to normal breast tissues 668103
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B6prostasin breast cancer cell strong expression association between matriptase and its substrate prostasin in breast cancer 717902
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.1cathepsin B breast cancer cell - 36625, 753138
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.15cathepsin L breast cancer cell - 752936, 755110
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.26cancer procoagulant breast cancer cell - 668137
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.34Legumain breast cancer cell legumain is overexpressed in the majority of human solid tumours, including breast cancer, colorectal cancer, ovarian cancer, prostate cancer and gastric cancer 752851
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.38cathepsin K breast cancer cell biopsy sites, benign lesions, ductal carcinoma in situ, and invasive breast tumors of different stages. Neither epithelial nor stromal expression of CTSK is significantly associated with recurrence-free or overall survival 697375
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.41cathepsin F breast cancer cell - 668085
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.49separase breast cancer cell increased expression of separase 697382
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.49separase breast cancer cell overexpressed in numerous human cancers including breast, bone, brain, and prostate 752903
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.49separase breast cancer cell Separase is significantly overexpressed in human breast tumors compared with matched normal tissue (Western blot) 700945
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.52calpain-1 breast cancer cell - 710164
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.53calpain-2 breast cancer cell - 732050
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.56caspase-3 breast cancer cell - 695620, 696872, 697055
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.56caspase-3 breast cancer cell a breast cancer Dox resistant MCF-7/Dox cell line 697054
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.59caspase-6 breast cancer cell - 647467
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.59caspase-6 breast cancer cell invasive operable pT1 and pT2 ductal breast carcinoma are analysed of 210 patients: caspase-6 is overexpressed in 52.9% 680072
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.61caspase-8 breast cancer cell - 695620, 697053, 697261
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.62caspase-9 breast cancer cell - 717277, 731452
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.63caspase-10 breast cancer cell - 710209
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B29calpain 9 breast cancer cell expression analysis 731549
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B70SENP1 peptidase breast cancer cell enzyme SENP1 levels are positively correlated with substrate Pin1 levels in human breast cancer specimens 731577
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B71SENP2 peptidase breast cancer cell weak expression, benign breast adenofibroma cell and malignant breast cancer tissue 732727
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B75SENP7 peptidase breast cancer cell - 731599, 732812
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.3gastricsin breast cancer cell - 668809
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.36Signal peptidase II breast cancer cell - 754940
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.5cathepsin D breast cancer cell - 695419, 695654, 711855, 755627
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B24signal peptide peptidase breast cancer cell high expression level 754940
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.18meprin A breast cancer cell - 733064
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.23matrilysin breast cancer cell early stage primary cancers, MMP-7 correlates with breast cancer development, overexpression of MMP-7 and ErbB4, overview 683331
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.35gelatinase B breast cancer cell - 696965, 708409, 709302, 710245
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.35gelatinase B breast cancer cell primary breast tumor cell 696965
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.56insulysin breast cancer cell - 683571
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.7interstitial collagenase breast cancer cell - 708587, 710246
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.80membrane-type matrix metalloproteinase-1 breast cancer cell - 638810, 708543, 754158
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.82ADAMTS-4 endopeptidase breast cancer cell - 754958
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell - 670445, 719935, 754703, 754704, 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell primary breast cancer cell BC1205 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell primary breast cancer cell BC1302 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B3matrix metalloproteinase-11 breast cancer cell - 708156, 753930
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B3matrix metalloproteinase-11 breast cancer cell breast tumor tissues display higher expression levels of MMP-11 than the adjacent non-cancerous tissues 708173
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B3matrix metalloproteinase-11 breast cancer cell cancer cell-adipocyte interaction/crosstalk during the initial steps of cancer cell invasion 668150
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B3matrix metalloproteinase-11 breast cancer cell samples from patients with histologically confirmed diagnosis of early invasive breast cancers of ductal types, expression of MMP-11 is increased and more heterogeneous in metastatic specimens compared to non-metastatic tumour samples, quantitative expression and mapping of the cancer biomarker MMP-11 in human breast cancer tissue sections, overview 752463
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B4matrix metalloproteinase-13 breast cancer cell - 691486, 712933
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B4matrix metalloproteinase-13 breast cancer cell expression of MMP13 in tumors 711675
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B7matrix metalloproteinase-26 breast cancer cell elevated MMP-26 expression level 710794
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.12biotinidase breast cancer cell analysis of gene expression in breast cancer plasma, diverse tissue samples, profiling, overview 711589
Show all pathways known for 3.5.1.2Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.2glutaminase breast cancer cell - 670391, 694485
Show all pathways known for 3.5.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.23ceramidase breast cancer cell - 733498
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.98histone deacetylase breast cancer cell - 711660
Show all pathways known for 3.5.2.9Display the word mapDisplay the reaction diagram Show all sequences 3.5.2.95-oxoprolinase (ATP-hydrolysing) breast cancer cell - 694485
Show all pathways known for 3.5.4.4Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.4adenosine deaminase breast cancer cell - 718704
Show all pathways known for 3.5.4.4Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.4adenosine deaminase breast cancer cell the activity of isozyme ADA2 is increased 668272
Display the word mapDisplay the reaction diagram Show all sequences 3.6.1.625'-(N7-methylguanosine 5'-triphospho)-[mRNA] hydrolase breast cancer cell - 758325
Display the word mapDisplay the reaction diagram Show all sequences 3.6.4.13RNA helicase breast cancer cell - 756284
Display the word mapDisplay the reaction diagram Show all sequences 3.6.4.13RNA helicase breast cancer cell deregulated expression of p68 in breast cancer. The DDX5 locus is consistently strengthened in breast cancer and is usually overexpressed in association with ERBB2. Various breast cancer cell lines exhibit different dependence on DDX5 expression 757299
Display the word mapDisplay the reaction diagram Show all sequences 3.6.4.B10chaperonin ATPase (protein-folding, protecting from aggregation, protein stabilizing) breast cancer cell - 756668
Display the word mapDisplay the reaction diagram Show all sequences 3.6.5.2small monomeric GTPase breast cancer cell mRNA levels of RasL10B are down-regulated in all breast cancer cells tested (HBL100, MCF7, MDA-MB-468, MDA-MB-231 and MDA-MB-435. RasL10B) is a member of ras superfamily with tumor suppressor potential 668060
Show all pathways known for 4.1.1.17Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.17ornithine decarboxylase breast cancer cell - 682982, 695299
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22histidine decarboxylase breast cancer cell HDC expression is significantly increased in carcinoma cells 691585
Show all pathways known for 4.1.1.28Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.28aromatic-L-amino-acid decarboxylase breast cancer cell different splicing variants 748845
Show all pathways known for 4.1.1.9Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.9malonyl-CoA decarboxylase breast cancer cell - 706013
Show all pathways known for 4.2.1.11Display the word mapDisplay the reaction diagram Show all sequences 4.2.1.11phosphopyruvate hydratase breast cancer cell - 702980
Show all pathways known for 4.2.1.11Display the word mapDisplay the reaction diagram Show all sequences 4.2.1.11phosphopyruvate hydratase breast cancer cell cell surface ENOA is enhanced 714970
Show all pathways known for 4.3.2.1Display the word mapDisplay the reaction diagram Show all sequences 4.3.2.1argininosuccinate lyase breast cancer cell the enzynme is overexpressed in breast cancer 748794
Show all pathways known for 4.3.2.9Display the word mapDisplay the reaction diagram Show all sequences 4.3.2.9gamma-glutamylcyclotransferase breast cancer cell - 687744, 705761, 720332, 735747
Show all pathways known for 4.4.1.5Display the word mapDisplay the reaction diagram Show all sequences 4.4.1.5lactoylglutathione lyase breast cancer cell MDA-MD-231 cell, JIMT-1 cell 694824
Show all pathways known for 5.1.99.4Display the word mapDisplay the reaction diagram Show all sequences 5.1.99.4alpha-methylacyl-CoA racemase breast cancer cell - 681814, 727322
Display the word mapDisplay the reaction diagram Show all sequences 5.2.1.8peptidylprolyl isomerase breast cancer cell - 705066
Show all pathways known for 5.3.1.9Display the word mapDisplay the reaction diagram Show all sequences 5.3.1.9glucose-6-phosphate isomerase breast cancer cell - 703022
Display the word mapDisplay the reaction diagram Show all sequences 5.3.3.12L-dopachrome isomerase breast cancer cell - 748797
Show all pathways known for 5.3.3.8Display the word mapDisplay the reaction diagram Show all sequences 5.3.3.8DELTA3-DELTA2-enoyl-CoA isomerase breast cancer cell - 691485
Display the word mapDisplay the reaction diagram Show all sequences 5.6.2.1DNA topoisomerase breast cancer cell - 750368
Display the word mapDisplay the reaction diagram Show all sequences 5.6.2.2DNA topoisomerase (ATP-hydrolysing) breast cancer cell - 693362, 727888
Display the word mapDisplay the reaction diagram Show all sequences 5.6.2.2DNA topoisomerase (ATP-hydrolysing) breast cancer cell with a mutation in gene BRCA1 691488
Display the word mapDisplay the reaction diagram Show all sequences 6.2.1.15arachidonate-CoA ligase breast cancer cell a breast cancer cell model, comprising different cell lines, expresses ACSL4 in all cell lines, high expression level 716687
<< < Results 201 - 300 of 309 > >>
download as CSV
download all results as CSV